Search results
May 25, 2023 · NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) approved PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets) for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
Paxlovid – COVID-19 Antiviral Treatment | Walgreens. Walgreens pharmacists can now prescribe Paxlovid to help treat COVID-19. Learn more today and see if you are eligible for the antiviral treatment.
View All Updates. Important Information About Paxlovid. Paxlovid (nirmatrelvir co-packaged with ritonavir) is an oral antiviral drug that should be initiated as soon as possible within 5 days of symptom onset. Paxlovid is available for patients by prescription only.
